Tongsen Zheng

No. 23 Youzheng Street
Harbin, 150001, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 73 publications

Electroacupuncture combined with fruquintinib and sintilimab in microsatellite-stable metastatic colorectal cancer: A phase II study.

Electroacupuncture combined with fruquintinib and sintilimab in microsatellite-stable metastatic colorectal cancer: A phase II study.

Journal: Cancer letters

Published: November 18, 2025

Retraction Note to: KIFC1 regulated by miR-532-3p promotes epithelial-to-mesenchymal transition and metastasis of hepatocellular carcinoma via gankyrin/AKT signaling.

Retraction Note to: KIFC1 regulated by miR-532-3p promotes epithelial-to-mesenchymal transition and metastasis of hepatocellular carcinoma via gankyrin/AKT signaling.

Journal: Oncogene

Published: August 12, 2025

Precision targeting of STING: Challenges, innovations, and clinical outlook for cancer therapy.

Precision targeting of STING: Challenges, innovations, and clinical outlook for cancer therapy.

Journal: Innovation (Cambridge (Mass.))

Published: April 23, 2025

CD160 dictates anti-PD-1 immunotherapy resistance by regulating CD8+ T cell exhaustion in colorectal cancer.

CD160 dictates anti-PD-1 immunotherapy resistance by regulating CD8+ T cell exhaustion in colorectal cancer.

Journal: Nature cell biology

Published: December 30, 2024

An etiology-stratified single-cell atlas identifies FABP4 as a prognostic marker for MASLD-related HCC.

An etiology-stratified single-cell atlas identifies FABP4 as a prognostic marker for MASLD-related HCC.

Journal: Journal of hepatology

Published: December 17, 2024

Preclinical Development and Phase I Study of ZSYY001, a Polymeric Micellar Paclitaxel for Advanced Solid Tumor.

Preclinical Development and Phase I Study of ZSYY001, a Polymeric Micellar Paclitaxel for Advanced Solid Tumor.

Journal: Cancer medicine

Published: October 09, 2024

STING in cancer immunoediting: Modeling tumor-immune dynamics throughout cancer development.

STING in cancer immunoediting: Modeling tumor-immune dynamics throughout cancer development.

Journal: Cancer letters

Published: September 09, 2024

Early Cancer Detection Through Comprehensive Mapping of Dynamic Tumorigenesis.

Early Cancer Detection Through Comprehensive Mapping of Dynamic Tumorigenesis.

Journal: Cancer discovery

Published: July 28, 2024

Engineered outer membrane vesicles enhance solid tumour CAR-T cell therapy.

Engineered outer membrane vesicles enhance solid tumour CAR-T cell therapy.

Journal: Nature biomedical engineering

Published: June 25, 2024

Phase 1 trial of HR070803 (an Irinotecan liposome) in combination with 5-fluorouracil, leucovorin, and oxaliplatin for untreated advanced or metastatic pancreatic ductal adenocarcinoma.

Phase 1 trial of HR070803 (an Irinotecan liposome) in combination with 5-fluorouracil, leucovorin, and oxaliplatin for untreated advanced or metastatic pancreatic ductal adenocarcinoma.

Journal: BMC medicine

Published: May 31, 2024

Therapeutic targets of armored chimeric antigen receptor T cells navigating the tumor microenvironment.

Therapeutic targets of armored chimeric antigen receptor T cells navigating the tumor microenvironment.

Journal: Experimental hematology & oncology

Published: May 07, 2024

Neutrophil extracellular traps promote immune escape in hepatocellular carcinoma by up-regulating CD73 through Notch2.

Neutrophil extracellular traps promote immune escape in hepatocellular carcinoma by up-regulating CD73 through Notch2.

Journal: Cancer letters

Published: April 21, 2024

Showing 1-12 of 73

Last Updated: 09/26/2026